Medexus Pharmaceuticals Inc. (OTCMKTS:MEDXF – Get Free Report) traded up 0.2% on Tuesday . The stock traded as high as $2.8965 and last traded at $2.8950. 2,500 shares traded hands during trading, a decline of 79% from the average session volume of 11,693 shares. The stock had previously closed at $2.89.
Medexus Pharmaceuticals Stock Up 0.2%
The business has a fifty day simple moving average of $2.58 and a 200-day simple moving average of $2.21.
About Medexus Pharmaceuticals
Medexus Pharmaceuticals, Inc is a specialty pharmaceutical company headquartered in Mississauga, Ontario. The company focuses on acquiring, developing and commercializing niche prescription drug products for markets in Canada and the United States. Its efforts are aimed at underserved therapeutic areas, including rare diseases, oncology, hematology and dermatology.
Through strategic licensing and partnership agreements with international pharmaceutical firms, Medexus sources late‐stage and marketed assets, then manages their regulatory approval and commercialization.
Featured Stories
- Five stocks we like better than Medexus Pharmaceuticals
- Navy Catalyst Ignites Odysight’s Growth Engine
- AST SpaceMobile Plummets on Galactic Q1 Miss: Can Vertical Integration Save the SpaceX Rival?
- Axon Surged After Earnings and Is Still Down Over 50% From Highs
- The Event That Could Redefine Apple’s Summer Rally
Receive News & Ratings for Medexus Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medexus Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
